The data describing cancer risks associated with Lynch syndrome are variable.
C olorectal cancer (CRC) is the fourth most common cancer in the United States and is the second leading cause of cancer-related mortality. 1 Heritability is 1 of the strongest risk factors for CRC and familial clustering of CRC accounts for 25% to 30% of CRC. 2 Lynch syndrome is an autosomal-dominant syndrome that accounts for up to 5% of CRC and is characterized by as much as an 80% lifetime risk of CRC and several extracolonic cancers. Lynch syndrome has been associated with germ-line mutations in the MSH2, MLH1, MSH6, PMS2,o rEPCAM genes. 3, 4 Because families with Lynch syndrome have a markedly increased risk of CRC and screening can reduce morbidity and mortality in these individuals, several clinical criteria have been proposed to identify Lynch syndrome. 5 The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer defined the Amsterdam I and II criteria that are widely used to identify patients and families at risk for Lynch syndrome. 6, 7 Several studies that have evaluated cancer risk associated with Lynch syndrome [8] [9] [10] [11] have been limited by selection bias, insufficient confirmation of cancer diagnosis in relatives, and lack of reliable population-based controls.
In the present study, we used the Utah Population Database (UPDB; http://healthcare.utah.edu/huntsmancancerinstitute/research/updb/), a unique resource linking genealogy and cancer data for the state, to identify families classified by Amsterdam criteria in an unbiased manner. The objective was to investigate cancer risks in patients and their relatives from families that meet Amsterdam criteria and are at risk for Lynch syndrome.
Methods

Design
We performed a retrospective, population-based, casecontrol study of cancers diagnosed in Utah between 1966 and 2013 and recorded in the Utah Cancer Registry (UCR) merged with UPDB genealogies to investigate the familial aggregation of cancers. The UPDB combines genealogies from the Genealogical Society of Utah, dating back to the early 1800s, and includes nearly 8 million individuals. The UCR is a statewide cancer registry established in 1966 and, since 1973, it has been part of the Surveillance, Epidemiology, and End Results Program network of the National Cancer Institute registries. By state law, all incident cancer diagnoses must be reported to the UCR. This study was approved by the institutional review boards of the University of Utah, Intermountain Healthcare, and the Resource for Genetic and Epidemiologic Research. Data are deidentified.
Study Case Population
Within the set of 17 087 CRC cases records from UCR during 1966-2013, we identified all clusters of CRC cases that matched the Amsterdam I or II criteria, described in eTable 1 in the Supplement. Only individuals who were members of families with at least 4 generations were considered in the present study. Patients who had a diagnosis of familial adenomatous polyposis (confirmed APC mutation) in our institution's hereditary gastrointestinal cancer registry, which cares for most such families in Utah, were excluded from the study population.
Familial Risk Analysis
Familial risk was measured using standardized morbidity ratios (SMRs) or relative risk. The SMRs in relatives, using ageand sex-matched cancer rates, were estimated from the UPDB and are detailed in the eMethods of the Supplement. 12 
Results
Fifty-nine families fulfilled the Amsterdam I criteria and 202 families (including the 59 with Amsterdam I criteria) fulfilled the Amsterdam II criteria (eTable 2 in the Supplement). Among the 17 087 patients in the Utah population affected by colorectal cancer, 443 (2.6%) of the cases were members of the families that fulfilled the Amsterdam criteria.
We analyzed the risk of extracolonic cancers in the proband cancer cases in the families that fulfilled the Amsterdam I or II criteria ( Table 1 and Table 2 ). Proband cases who were members of Amsterdam I criteria families were at increased risk for endometrial cancer (SMR, 6.14; 95% CI, 2.25-13.37). Findings In a population-based study, all Amsterdam criteria-positive pedigrees in Utah were ascertained and 202 families with 443 colorectal cancers that accounted for 2.6% of all colorectal cancer in the state were identified. Cancers observed in significant excess in the first-degree relatives of Amsterdam criteria pedigrees included colorectal, endometrial, stomach, small intestine, prostate, kidney, and bladder cancer, as well as non-Hodgkin lymphoma; the risk of colorectal and endometrial cancers was also found to be elevated in second-degree and first-cousin relatives of families with Amsterdam criteria.
Meaning This study provides clinicians with population-based, unbiased data to counsel members of families with Amsterdam criteria regarding their elevated risks of cancer and the importance of cancer screening.
(SMR, 7.72; 95% CI, 5.17-11.08) cancer. Colorectal and endometrial cancers were elevated in both second-degree relatives (SMR, 4.31; 95% CI, 3.98-4.65 for CRC and SMR, 2.70; 95% CI, 2.30-3.14 for endometrial cancer) and first cousins (SMR, 1.85; 95% CI, 1.70-2.00 for CRC and SMR, 1.50, 95% CI, 1.29-1.73 for endometrial cancer). Similar elevated cancer risks were found for relatives of families meeting Amsterdam I criteria. In addition to the commonly affected cancer sites in Lynch syndrome, our study suggested an increased risk of several extracolonic rare cancers, which is in agreement with other studies. 8, 9, 11, 14 This information for nontypical cancers may add to the clinical criteria for Lynch syndrome.
Strengths and Limitations
Our study has several strengths. We took advantage of the unique linkage of the UPDB to UCR to confirm cancer diagnosis and familial relationships spanning multiple generations without ascertainment, referral, or recall bias. The ability to exclude patients with familial adenomatous polyposis in this study has likely reduced bias in terms of cancer risk assessment in families with multiple generations of CRC. The present study also has limitations. Affiliation with the Church of Jesus Christ of Latter-day Saints is associated with low rates of smoking and alcohol use in this population and could also differ from other populations; in addition, other hereditary cancer syndromes could not be excluded.
Conclusions
We found that 2.6% of CRC cases in Utah fulfilled the Amsterdam criteria and that CRC and endometrial cancer should be the focus of clinical counseling in these families.
In addition, we found that a number of other rarely noted sites appear to be observed in excess in these families and second-degree relatives of probands in families meeting Amsterdam criteria are at markedly increased risk of CRC and should be counseled to initiate colorectal screening at an earlier age and a shorter surveillance interval. This study provides clinicians with population-based, unbiased data to counsel members of Amsterdam criteria families regarding their elevated risks of cancer and the importance of cancer screening.
